Literature DB >> 3959004

Eimeria tenella: parasite-specific incorporation of 3H-uracil as a quantitative measure of intracellular development.

D M Schmatz, M S Crane, P K Murray.   

Abstract

An assay has been developed using parasite-specific incorporation of 3H-uracil to assess the intracellular growth of Eimeria tenella in vitro. As shown by both scintillation counts and autoradiography, 3H-uracil was incorporated specifically into intracellular parasites from the onset of infection and continued throughout development of the first generation schizonts. Mature schizonts and first generation merozoites did not continue to incorporate additional 3H-uracil, indicating that RNA synthesis had halted in these stages. Based on these findings, a semi-automated microscale uracil incorporation assay was developed to determine parasite viability. This method should be useful for biochemical studies with intracellular parasites and for screening compounds for anticoccidial activity. The ease, rapidity, and quantitative nature of this assay contrasts favorably with standard morphometric approaches of determining parasite development. In addition, parallel studies using host cell incorporation of 3H-uridine have been introduced as a method of determining whether antiparasitic activity is direct or indirect in relation to effects on the host cell.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3959004     DOI: 10.1111/j.1550-7408.1986.tb05568.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  10 in total

1.  Further investigation of anticoccidial activity of 7-bromo-N-(2-imidazolidinylidene)-1H-indazol-6-amine.

Authors:  A P Ricketts; J W McFarland; D M Newcomb; J A Olson; J R Rice
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  In vivo expression of in vitro anticoccidial activity.

Authors:  A P Ricketts; J A Olson; J R Rice
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

3.  In situ enzyme-linked immunosorbent assay to quantitate in vitro development of Eimeria tenella.

Authors:  J A Olson
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

4.  Comparative development of Eimeria tenella (Apicomplexa) in host cells in vitro.

Authors:  J Tierney; G Mulcahy
Journal:  Parasitol Res       Date:  2003-04-01       Impact factor: 2.289

5.  Incorporation of exogenous uracil by Cryptosporidium parvum in vitro.

Authors:  S J Upton; M Tilley; R R Mitschler; B S Oppert
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

6.  Improved techniques for the in vitro cultivation of Eimeria tenella in primary chick kidney cells.

Authors:  J Hofmann; W Raether
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

7.  Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.

Authors:  S J Darkin-Rattray; A M Gurnett; R W Myers; P M Dulski; T M Crumley; J J Allocco; C Cannova; P T Meinke; S L Colletti; M A Bednarek; S B Singh; M A Goetz; A W Dombrowski; J D Polishook; D M Schmatz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

8.  Combination of cell culture and qPCR to assess the efficacy of different anticoccidials on Eimeria tenella sporozoites.

Authors:  Ahmed Thabet; Alaa Aldin Alnassan; Arwid Daugschies; Berit Bangoura
Journal:  Parasitol Res       Date:  2015-03-14       Impact factor: 2.289

Review 9.  In Vitro Assessment of Anticoccidials: Methods and Molecules.

Authors:  Martina Felici; Benedetta Tugnoli; Andrea Piva; Ester Grilli
Journal:  Animals (Basel)       Date:  2021-06-30       Impact factor: 2.752

10.  Establishment of an in vitro chicken epithelial cell line model to investigate Eimeria tenella gamete development.

Authors:  Françoise I Bussière; Alisson Niepceron; Alix Sausset; Evelyne Esnault; Anne Silvestre; Robert A Walker; Nicholas C Smith; Pascale Quéré; Fabrice Laurent
Journal:  Parasit Vectors       Date:  2018-01-18       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.